Alveron Pharma

Biotechnology company developing a coagulation platform and a cyclodextrin-based drug to reverse the effects of anticoagulants

Biotech & Life Sciences

Sector

B2B biotechnology

Model

01Company Overview

Biotechnology company developing a coagulation platform and a cyclodextrin-based drug to reverse the effects of anticoagulants.

02Backed By1 investor

03Similar Companies

LT

Lunac Therapeutics

Biotech & Life Sciences

→

HT

PP

A

TB

04Startup DNA

8

signals

Sectors
Business Model
Technology